|
Medtronic Recall of Heart Leads occurs after Patient Deaths
Medtronic Recall of Heart Leads occurs after Patient Deaths
The Medtronic recall of heart leads was prompted when the company identified at least five patient deaths in which a Medtronic Sprint Fidelis lead fractured and was a likely contributing factor to the death. The Medtronic recall of the heart defibrillator / pacemaker leads includes the Sprint Fidelis Models: 6930, 6931, 6948, and 6949. These defective heart leads are used with non – Medtronic defibrillators and non – Medtronic pacemakers as well as Medtronic defibrillators and pacemakers. People with defibrillators and pacemakers should check the patient implant card that they received after their implant surgery to determine if they received one of the leads in the Medtronic recall. Patients should contact their physician if there is any uncertainty about being implanted with one of the recalled leads.
If you or a loved one has been implanted with a Medtronic Sprint Fidelis Model 6930, 6931, 6948, or 6949 defibrillator lead then you should call us toll free now at 1-866-374-0338 because you may be entitled to medical monitoring and compensation from the manufacturer. Our Medtronic recall lawyers are currently investigating claims for individual Medtronic lawsuit claims and Medtronic class action claims
We have represented clients in every state and helped thousands of injured clients nationwide make recoveries for their injuries. We are ready to help you! Our clients are never at risk of paying any fees, expenses, or costs out of pocket. All fees costs and expenses are paid only out of any recovery we make for you. Do not delay. Contact us now to find out if we can help. The claim evaluation is free. All claims have strict time limitations which will bar any recovery you or your loved may be entitled if the claim is not brought on time.
FDA Statement on Medtronic's Voluntary Market Suspension of Their Sprint Fidelis Defibrillator Leads Statement by Daniel Schultz, M.D., director of the Center for Devices and Radiological Health: Medtronic's decision to voluntarily remove its Sprint Fidelis defibrillation leads from the market is in the best interest of patient safety. These electronic wires are prone to fracture in a small number of patients which can cause the defibrillator to deliver unnecessary shocks or not operate at all. Based on our initial review of reported adverse events, some deaths and major complications have occurred after the leads have fractured.
| ||


Medtronic Recall - Lead Replacement Recall Lawyers 














